|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.300 EUR | +1.22% |
|
-0.72% | +32.80% |
| Market Cap | 4.62Cr 5.26Cr 4.3Cr 3.94Cr 7.41Cr 506.42Cr 7.52Cr 51Cr 20Cr 248.97Cr 20Cr 19Cr 860.82Cr | P/E 2026 * |
-21x | P/E 2027 * | 205x |
|---|---|---|---|---|---|
| Enterprise Value | 4.47Cr 5.09Cr 4.16Cr 3.81Cr 7.17Cr 489.97Cr 7.28Cr 49Cr 19Cr 240.89Cr 19Cr 19Cr 832.87Cr | EV / Sales 2026 * |
4.06x | EV / Sales 2027 * | 2.83x |
| Free-Float |
29.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +1.22% | ||
| 1 week | -0.72% | ||
| Current month | +6.96% | ||
| 1 month | +9.79% | ||
| 3 months | +8.64% | ||
| 6 months | +18.57% | ||
| Current year | +32.80% |
| 1 week | 7.66 | 8.44 | |
| 1 month | 7.46 | 8.94 | |
| Current year | 6 | 9.1 | |
| 1 year | 5.5 | 9.1 | |
| 3 years | 2.14 | 9.1 | |
| 5 years | 1.9 | 9.1 | |
| 10 years | 1.9 | 9.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 29/12/2008 | |
Renaut Fritsch
DFI | Director of Finance/CFO | - | 01/06/2022 |
Thibaut Bastien
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2021 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.22% | -0.72% | -2.35% | +237.40% | 5.25Cr | ||
| +0.86% | +1.22% | +48.18% | +159.84% | 1,05700Cr | ||
| +1.62% | +4.09% | +55.34% | +53.96% | 62TCr | ||
| +0.87% | +1.93% | +35.93% | +81.16% | 45TCr | ||
| +1.60% | +6.25% | +33.95% | +29.84% | 34TCr | ||
| -0.60% | +1.52% | +35.68% | +39.76% | 30TCr | ||
| -0.14% | +0.60% | +16.17% | +17.53% | 26TCr | ||
| +0.09% | -2.82% | -28.29% | -41.71% | 22TCr | ||
| +1.15% | +2.98% | +22.25% | +60.22% | 20TCr | ||
| -1.23% | -3.18% | +14.85% | +67.41% | 16TCr | ||
| Average | +0.59% | +0.51% | +23.17% | +70.54% | 36.14TCr | |
| Weighted average by Cap. | +0.76% | +1.57% | +35.69% | +77.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1Cr 1.25Cr 1.02Cr 93.87L 1.76Cr 120.61Cr 1.79Cr 12Cr 4.75Cr 59Cr 4.7Cr 4.6Cr 205.02Cr | 1.6Cr 1.82Cr 1.49Cr 1.37Cr 2.57Cr 175.43Cr 2.61Cr 18Cr 6.9Cr 86Cr 6.84Cr 6.69Cr 298.21Cr |
| Net income | -22.5L -25.62L -20.92L -19.2L -36.08L -25Cr -36.63L -2.48Cr -97.08L -12Cr -96.17L -94.1L -42Cr | 2L 3L 2L 2L 4L 2.74Cr 4L 27.61L 10.79L 1.35Cr 10.69L 10.46L 4.66Cr |
| Net Debt | -15L -17.08L -13.95L -12.8L -24.05L -16Cr -24.42L -1.66Cr -64.72L -8.09Cr -64.11L -62.73L -28Cr | -9L -10.25L -8L -8L -14.43L -9.87Cr -14.65L -99.39L -38.83L -4.85Cr -38.47L -37.64L -17Cr |
Employees
45
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | €8.300 | +1.22% | 312 |
| 23/26/23 | €8.200 | +5.13% | 396 |
| 22/26/22 | €7.800 | -7.14% | 404 |
| 21/26/21 | €8.400 | +0.72% | 169 |
| 20/26/20 | €8.340 | +10.32% | 3,069 |
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
8.200EUR
Average target price
8.200EUR
Spread / Average Target
0.00%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALSMA Stock
Select your edition
All financial news and data tailored to specific country editions
















